Intec Pharma (Israel) Financial Indicators Patterns

NTEC -- Israel Stock  

null 1,495  5.00  0.34%

We strongly advise you to harness Intec Pharma fundamental analysis to see if markets are presently mispricing the organization. In other words this interface allows you to validate available fundamentals of Intec Pharma as well as the relationship between them. . We found seventeen available reported financial drivers for Intec Pharma which can be compared to its competitors. Use Intec Pharma Ltd Current Ratio, Cash Flow from Operations, Number of Employees, as well as the relationship between Book Value Per Share and Earnings Per Share to make sure your decision on pricing Intec Pharma is adequate. Use Intec Pharma to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Intec Pharma to be traded at 1569.75 in 30 days.

Intec Pharma Company Summary

Intec Pharma competes with Elbit Systems, Electra Ltd, and Clal Insurance. Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Intec Pharma Ltd. was founded in 2000 and is based in Jerusalem, Israel. Intec Pharma operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. It employs 70 people.

Intec Pharma Return On Asset vs Cash Flow from Operations

Intec Pharma Ltd is regarded fourth in return on asset category among related companies. It is regarded fourth in cash flow from operations category among related companies .

Intec Pharma Market Fundamentals

 Change(%) 0.34%

Distress Rating

Intec Pharma Financial Distress Probability

Chance of Financial Distress
Intec Pharma Ltd has less than 41 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Intec Pharma

Compare Intec Pharma To Peers

Intec Pharma Opportunity Range

March 23, 2019 Opportunity Range

Please see also Stocks Correlation. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.